Should microtubule-stabilizing drugs be reconsidered as therapeutic targets for tauopathies given tau's destabilizing role?

Analysis ID: SDA-2026-04-15-gap-pubmed-20260410-100455-ff18091d | Domain: neurodegeneration | Status: completed | Created: 2026-04-15T12:32:38.248996

Knowledge Graph: 2 edges — View JSON

Top Hypotheses (2 total)

#1 DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxicity Without Directly Targeting Tau

0.609

MAP2K7/MAP3K12

# DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxicity Without Directly Targeting Tau ## Background and Therapeutic Rationale Tau pathology remains one of the defining hallmarks of Alzheim

#2 DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against Tau-Induced Destabilization

0.579

DAPK1

# DAPK1 Inhibition as Dual-Mechanism Neuroprotection Against Tau-Induced Destabilization ## Mechanistic Framework Death-Associated Protein Kinase 1 (DAPK1) occupies a pivotal position at the interse

← Back to all analyses